Table 1.
Value | |
---|---|
Number of patients with IPF | 1737 |
Total follow-up period (patient-years) | 3720 |
Median follow-up in years (IQR) | 2.0 (0.9–3.2) |
Sociodemographic characteristics at index date | |
Male sex, n (%) | 1173 (67.5) |
Age at index date (years), mean (SD) | 72.1 (10.4) |
Insurance status at index date, n (%) | |
Retired | 1489 (85.7) |
Employed | 143 (8.2) |
Unemployed | 51 (2.9) |
Voluntarily insured | 37 (2.1) |
Family-insured | 17 (1.0) |
Comorbidities in baseline period | |
CCI score at index date, median (IQR) | 4.0 (2.0–6.0) |
Lung cancer, n (%) | 106 (6.1) |
COPD, n (%) | 691 (39.8) |
Asthma, n (%) | 282 (16.2) |
Heart failure, n (%) | 622 (35.8) |
Arterial hypertension, n (%) | 1411 (81.2) |
Type 2 diabetes mellitus, n (%) | 647 (37.2) |
GERD, n (%) | 418 (24.1) |
Chronic ischemic heart disease, n (%) | 667 (38.4) |
Dyslipidemia, n (%) | 889 (51.2) |
Outpatient visits, hospitalizations, and procedures in baseline period | |
Number of GP visits per patient, mean (SD) | 4.6 (1.8) |
Number of pulmonologist visits per patient, mean (SD) | 0.9 (1.2) |
Number of other specialist visits per patient, mean (SD) | 10.1 (6.2) |
Number of all-cause hospitalizations per patient, mean (SD) | 1.1 (1.8) |
Number of days spent in hospital per patient, mean (SD) | 8.2 (18.5) |
Lung transplant, n (%) | 7 (0.4) |
Top five prescribed drug classes in baseline period, n (%) | |
Proton pump inhibitors | 787 (45.3) |
Beta blocking agents, selective | 774 (44.6) |
Statins | 641 (36.9) |
Sulfonamide-diuretics, plain | 590 (34.0) |
Pyrazalones | 518 (29.8) |
Top five inpatient main diagnoses in baseline period, n (%) | |
Pneumonia | 102 (5.9) |
Heart failure | 90 (5.2) |
COPD | 65 (3.7) |
Neoplasm of uncertain behavior of middle ear and respiratory and intrathoracic organs | 41 (2.4) |
Chronic ischemic heart disease | 36 (2.1) |
The respective baseline period is 12 months prior to the index date. “Retired” includes pension applicants; For the respective ATC, OPS, and ICD-10-GM codes, see Additional file 1: Table S3
ATC Anatomical Therapeutic Chemical, CCI Charlson Comorbidity Index, COPD chronic obstructive pulmonary disease, GERD gastroesophageal reflux disease, GP general practitioner, ICD-10-GM German Modification of the International Classification of Diseases, IPF idiopathic pulmonary fibrosis, IQR interquartile range, OPS Operationen-und Prozedurenschlüssel/operation and procedure classification, SD standard deviation